Recent Posts
Connect with:
Thursday / May 30.
HomemiophthalproductsHigh Frequency Deep Sclerotomy

High Frequency Deep Sclerotomy

Minimally invasive glaucoma surgery (MIGS) has established itself in the modern glaucoma management regime to effectively reduce intraocular pressure (IOP).

High frequency deep sclerotomy (HFDS, Oertli Instrumente AG, Switzerland) is a short, implant-free approach to be performed in combination with cataract surgery or as a stand-alone application.

Available on Oertli’s Catarhex3, Faros, and OS4 phaco platforms, the Abee glaucoma tip consists of a coaxial electrode that is used to create six small pockets in the iridocorneal angle for a direct channel between the anterior chamber and Schlemm’s canal, bypassing the resistance of the trabecular meshwork.

Results have demonstrated a mean preoperative IOP of 24.5 ±2.1mmHg. After 48 months, the follow-up average IOP was 15.0 ±1.7mmHg with no serious complications observed.1

Contact: Device Technologies (AUS) 1800 804 006

1. Pajic, B., et al., High-frequency deep sclerotomy, A minimal invasive ab interno glaucoma procedure combined with cataract surgery: Physical properties and clinical outcome. Appl. Sci. 2020, 10, 218. doi.org/10.3390/app10010218.